Tech Company Financing Transactions
Nutromics Funding Round
Nutromics secured a $14 million funding round on 9/8/2022. Investors included Artesian Investment, Dexcom and VU Venture Partners.
Transaction Overview
Company Name
Announced On
9/8/2022
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This latest round of funding will support an expansion of clinical studies, expansion of R&D team and investment across both Australian and United States hubs.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
420 Victoria St.
Brunswick VIC, 3056
Australia
Brunswick VIC, 3056
Australia
Phone
Undisclosed
Website
Email Address
Overview
Nutromics' vision is to create a world with zero preventable deaths due to the lack of timely molecular patient data. Nutromics' CMM platform will provide clinicians with continuous, and real-time insights into vancomycin concentrations, assisting with dosing and improving patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hitesh Mehta
Chief Executive Officer
Peter Vranes
Browse more venture capital transactions:
Prev: 9/8/2022: Live Earth venture capital transaction
Next: 9/8/2022: Figures venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs